Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	42.36	-139.18	-241.47
Graham Fair Price	-44.96	0.39	0.71
PEG	544.78	0.35	-0.05
Price/Book	-19.57	8.99	11.18
Price/Cash Flow	-37.62	-391.45	627.50
Prices/Earnings	-185.06	-24.87	-8.72
Price/Sales	43.96	119.23	82.83
Price/FCF	-37.62	-391.45	627.50
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-55.30	0.02	-0.05
Operating Margin	52.19	-1.07	-2.23
ROA	73.71	-0.02	-0.08
ROE	-0.32	-0.09	71.79
ROIC	-0.10	-0.03	73.63
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.02	-68.48
Dividends QOQ	-0.19	0.35	79.35
EBIT QOQ	-1.80	0.76	-58.00
EPS QOQ	-1.60	0.71	-55.79
FCF QOQ	1.35	-2.18	61.16
Revenue QOQ	0.26	-0.49	89.19
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	125.77	254.09	102.02
Days Sales Outstanding (DSO)	655.31	1312.87	100.34
Inventory Turnover	0.72	0.35	-50.50
Debt/Capitalization	0.66	0.68	3.09
Quick Ratio	0.70	0.70	-0.82
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	0.26	0.27	3.61
Cash	0.14	0.15	6.15
Capex	< 0.005	< 0.005	-95.04
Free Cash Flow	< 0.005	< 0.005	33.59
Revenue	0.04	0.02	-42.11
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.00	0.98	-2.01
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-27.39	-21.12	22.90
Naive Interpretation	Member

06 - Financial Health · Bad

Rating